-
1by Minya Lu, Li Zhang, Yue Li, Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Xiaoyan Si, Yingchun Xu, Li Zhang“...Immune checkpoint inhibitors (ICIs) have been widely used in the management of malignant tumors...”
Published 2020-03-01
Get full text
Article -
2by Xiaoyan Si, Chunxia He, Li Zhang, Xiaowei Liu, Yue Li, Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Mengzhao Wang, Li Zhang“.... In this review, we summarize guidelines of management of immunotherapy‐related toxicities, case reports...”
Published 2020-02-01
Get full text
Article -
3by Jiaxin Zhou, Hanping Wang, Xiaoxiao Guo, Qian Wang, Lian Duan, Xiaoyan Si, Li Zhang, Xiaowei Liu, Yue Li, Wen Zhang, Li Zhang“...‐existing rheumatic diseases, and focus on the management of rheumatic irAEs....”
Published 2020-01-01
Get full text
Article -
4by Xiaoxiao Guo, Hanping Wang, Jiaxin Zhou, Yue Li, Lian Duan, Xiaoyan Si, Li Zhang, Ligang Fang, Li ZhangGet full text
Published 2020-02-01
Article -
5by Xiaoyan Si, Peng Song, Jun Ni, Mingyi Di, Chunxia He, Li Zhang, Xiaowei Liu, Yue Li, Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Xu Yang, Mengzhao Wang, Li Zhang“.... Management of irAEs is based on clinical experience because it is not easy to conduct prospective trials...”
Published 2020-03-01
Get full text
Article -
6by Xiaowei Liu, Zheng Wang, Chan Zhao, Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Xiaoyan Si, Li Zhang, Yue Li, Mengzhao Wang, Meifen Zhang, Li Zhang“... and advise on how to diagnose and manage these diseases. Key points This review will enable clinical...”
Published 2020-03-01
Get full text
Article -
7by Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Yue Li, Lian Duan, Xiaoyan Si, Li Zhang, Xiaowei Liu, Mengzhao Wang, Juhong Shi, Li Zhang“.... In this review, we summarize the characteristics of CIP and provide advice on how to manage this disease....”
Published 2020-01-01
Get full text
Article
